Showing results (181-190 of 3,204) with videos related to
Sort By:
Pageof 321
Leukemia & Lymphoma|March 18, 2000
Cost analyses of adjunct colony stimulating factors for acute leukemia: can they improve clinical decision makingC L Bennett, T J Stinson, J H Laver, et al.Archives of Internal Medicine|November 26, 1999
Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke preventionC L Bennett, C J Davidson, D W Raisch, et al.Journal of General Internal Medicine|October 1, 1996
AIDS-related Pneumocystis carinii pneumonia in older patientsS A Keitz, L A Bastian, C L Bennett, et al.Chest|February 12, 2000
Nosocomial tuberculosis prevention measures among two groups of US hospitals, 1992 to 1996L P Manangan, C L Bennett, N Tablan, et al.European Urology|January 1, 1997
A comparison of perspectives on prostate cancer: analysis of utility assessments of patients and physiciansC L Bennett, G Chapman, A S Elstein, et al.Annals of Internal Medicine|June 10, 1998
Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 casesC L Bennett, P D Weinberg, K Rozenberg-Ben-Dror, et al.Annals of Internal Medicine|April 1, 2000
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysisJ Seidenfeld, D J Samson, V Hasselblad, et al.Urology|April 18, 2001
Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic reviewB Schmitt, T J Wilt, P F Schellhammer, et al.Bone Marrow Transplantation|June 15, 2007
Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports projectC C Tigue, J M McKoy, A M Evens, et al.The Oncologist|October 25, 2001
Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patientsE A Calhoun, C H Chang, E E Welshman, et al.Pageof 321